• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体表面积封顶可能不会提高细胞毒性药物的耐受性。

Body surface area capping may not improve cytotoxic drugs tolerance.

机构信息

Medical Oncology Department, Lucien Neuwirth Cancer Center, 42270, Saint Priest en Jarez, France.

Pharmacy Department, Lucien Neuwirth Cancer Center, 42270, Saint-Priest en Jarez, France.

出版信息

Sci Rep. 2021 Jan 28;11(1):2431. doi: 10.1038/s41598-021-81792-6.

DOI:10.1038/s41598-021-81792-6
PMID:33510207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7843991/
Abstract

Capping body surface area (BSA) at 2 m is a routine clinical practice. It aims at reducing toxicities in over 2 m BSA patients. 455,502 computerized chemotherapy prescriptions made between 2011 and 2017 were taken from BPC software. Chemotherapy computerized order entry is created by a senior physician prescribers before patient consultation. Only prescriptions with dose calculation involving BSA were selected. 51,179 chemotherapy prescriptions were analyzed; corresponding to 7206 patients who received intravenous chemotherapy. The number of chemotherapy prescriptions in over 2 m BSA patients was nearly the same in the hematology as in the oncology departments. But, 79.1% of prescriptions were capped at 2 m in the oncology department contrary to 21.9% in the hematology department. Practices analysis showed more dose limitation in palliative situations in both departments. Unexpectedly, 6.53% of capped prescriptions were performed in patients with normal BMI. The patients who received capped doses of chemotherapy had neither fewer dose reductions due to toxicity nor deterioration of their general condition. Capping did not induce fewer dose reductions in patients with BSA greater than 2 m. Prospective studies in this population are needed to standardize chemotherapy administration in population with BSA > 2 m.

摘要

体表总面积(BSA)封顶至 2 平方米是一种常规的临床实践。其目的是降低 BSA 超过 2 平方米患者的毒性。从 BPC 软件中提取了 2011 年至 2017 年间的 455502 份计算机化疗处方。化疗计算机医嘱录入是由资深医师在患者咨询前创建的。仅选择涉及 BSA 剂量计算的处方。分析了 51179 份化疗处方;对应于接受静脉化疗的 7206 名患者。BSA 超过 2 平方米的患者的化疗处方数量在血液科和肿瘤科几乎相同。但是,肿瘤科有 79.1%的处方被封顶至 2 平方米,而血液科仅有 21.9%。实践分析显示,两个科室的姑息治疗情况下,剂量限制更多。出乎意料的是,6.53%的封顶处方是在 BMI 正常的患者中进行的。接受封顶剂量化疗的患者,由于毒性而减少剂量或一般状况恶化的情况并不多。BSA 大于 2 平方米的患者,封顶并未导致减少剂量。需要对该人群进行前瞻性研究,以标准化 BSA>2 m 人群的化疗管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c892/7843991/bff1b138cd14/41598_2021_81792_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c892/7843991/bff1b138cd14/41598_2021_81792_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c892/7843991/bff1b138cd14/41598_2021_81792_Fig1_HTML.jpg

相似文献

1
Body surface area capping may not improve cytotoxic drugs tolerance.体表面积封顶可能不会提高细胞毒性药物的耐受性。
Sci Rep. 2021 Jan 28;11(1):2431. doi: 10.1038/s41598-021-81792-6.
2
Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.体表面积(BSA)>2 m² 的妇科癌症患者的化疗毒性
Gynecol Oncol. 2009 Jul;114(1):53-6. doi: 10.1016/j.ygyno.2009.03.010. Epub 2009 Apr 8.
3
The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.基于体重的化疗剂量对一组妇科肿瘤患者的影响。
Gynecol Oncol. 2015 Jul;138(1):154-8. doi: 10.1016/j.ygyno.2015.04.040. Epub 2015 May 6.
4
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.根据未调整的体表面积,接受密集剂量(dd)化疗的肥胖患者严重毒性发生率较高:前瞻性随机 GAIN 研究的结果。
Ann Oncol. 2016 Nov;27(11):2053-2059. doi: 10.1093/annonc/mdw315. Epub 2016 Aug 8.
5
Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.非转移性结肠癌诊断时的肌肉量以及辅助性FOLFOX化疗的早期停药、延迟和剂量减少:C-SCANS研究
Cancer. 2017 Dec 15;123(24):4868-4877. doi: 10.1002/cncr.30950. Epub 2017 Sep 7.
6
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.抗癌药物的剂量计算:当前实践回顾与一种替代方法介绍
J Clin Oncol. 1996 Sep;14(9):2590-611. doi: 10.1200/JCO.1996.14.9.2590.
7
Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index.肥胖与癌症化疗中的剂量个体化:体表面积和体重指数的作用
Med Hypotheses. 2005;65(4):748-51. doi: 10.1016/j.mehy.2005.04.023.
8
Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.基于体重指数和实际体重的新辅助化疗剂量对可手术乳腺癌病理完全缓解的影响
Clin Breast Cancer. 2016 Dec;16(6):480-486. doi: 10.1016/j.clbc.2016.06.008. Epub 2016 Jun 23.
9
Optimal prescription method for cancer chemotherapy.癌症化疗的最佳处方方法。
Exp Hematol. 1985;13 Suppl 16:57-63.
10
Body surface area estimation in children using weight alone: application in paediatric oncology.仅使用体重估算儿童体表面积:在儿科肿瘤学中的应用
Br J Cancer. 2001 Jul 6;85(1):23-8. doi: 10.1054/bjoc.2001.1859.

引用本文的文献

1
Influence of capping chemotherapy prescriptions on efficacy and tolerability in medium and high-risk early-stage breast cancer.封顶化疗方案对中高危早期乳腺癌疗效和耐受性的影响。
Sci Rep. 2025 Aug 4;15(1):28415. doi: 10.1038/s41598-025-14279-3.
2
Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments.当前结直肠癌化疗的剂量限制及个性化治疗的新评估方法。
ANZ J Surg. 2022 Nov;92(11):2784-2785. doi: 10.1111/ans.18046.
3
Obesity reduced survival with 5-fluorouracil and did not protect against chemotherapy-induced cachexia or immune cell cytotoxicity in mice.

本文引用的文献

1
Modern pharmacological treatment of obese patients.肥胖患者的现代药物治疗。
Ther Adv Endocrinol Metab. 2020 Jan 22;11:2042018819897527. doi: 10.1177/2042018819897527. eCollection 2020.
2
Obesity and chemotherapy administration: between empiric and mathematic method review.肥胖与化疗药物给药:经验与数学方法综述。
Acta Oncol. 2019 Jun;58(6):880-887. doi: 10.1080/0284186X.2019.1585942. Epub 2019 Mar 23.
3
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
肥胖降低了氟尿嘧啶治疗的存活率,并且不能预防化疗引起的恶病质或免疫细胞细胞毒性。
Cancer Biol Ther. 2022 Dec 31;23(1):1-15. doi: 10.1080/15384047.2022.2108306.
4
Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.肥胖患者的化疗与抗癌药物调整:一项叙述性综述
Curr Med Chem. 2023;30(9):1003-1028. doi: 10.2174/0929867329666220806140204.
5
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysis.基于模型的群体药代动力学分析:药物遗传学对儿科患者口服长春瑞滨暴露变异性的影响。
Cancer Chemother Pharmacol. 2022 Jul;90(1):29-44. doi: 10.1007/s00280-022-04446-y. Epub 2022 Jun 25.
肥胖 III 期结肠癌患者化疗剂量减少的临床后果:来自 PETACC 3 研究的回顾性分析。
Eur J Cancer. 2018 Aug;99:49-57. doi: 10.1016/j.ejca.2018.05.004. Epub 2018 Jun 15.
4
Computer tomography-based body surface area evaluation for drug dosage: Quantitative radiology versus anthropomorphic evaluation.基于计算机断层扫描的体表面积评估用于药物剂量计算:定量放射学与人体测量评估
PLoS One. 2018 Feb 14;13(2):e0192124. doi: 10.1371/journal.pone.0192124. eCollection 2018.
5
Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.根据未调整的体表面积,接受密集剂量(dd)化疗的肥胖患者严重毒性发生率较高:前瞻性随机 GAIN 研究的结果。
Ann Oncol. 2016 Nov;27(11):2053-2059. doi: 10.1093/annonc/mdw315. Epub 2016 Aug 8.
6
Body surface area formulae: an alarming ambiguity.体表面积公式:令人担忧的模糊性。
Sci Rep. 2016 Jun 21;6:27966. doi: 10.1038/srep27966.
7
Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.早期乳腺癌化疗女性患者中根据体重指数和剂量限制划分的发热性中性粒细胞减少率
Clin Oncol (R Coll Radiol). 2016 Sep;28(9):597-603. doi: 10.1016/j.clon.2016.02.003. Epub 2016 Feb 28.
8
The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.基于体重的化疗剂量对一组妇科肿瘤患者的影响。
Gynecol Oncol. 2015 Jul;138(1):154-8. doi: 10.1016/j.ygyno.2015.04.040. Epub 2015 May 6.
9
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.适合癌症肥胖成年患者的化疗剂量:美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2012 May 1;30(13):1553-61. doi: 10.1200/JCO.2011.39.9436. Epub 2012 Apr 2.
10
Chemotherapy dose reductions in obese patients with colorectal cancer.肥胖结直肠癌患者的化疗剂量减少。
Ann Oncol. 2012 Mar;23(3):748-753. doi: 10.1093/annonc/mdr277. Epub 2011 Jun 6.